269 related articles for article (PubMed ID: 19571677)
1. Lipocalin 2: a multifaceted modulator of human cancer.
Yang J; Moses MA
Cell Cycle; 2009 Aug; 8(15):2347-52. PubMed ID: 19571677
[TBL] [Abstract][Full Text] [Related]
2. Lipocalin 2 promotes breast cancer progression.
Yang J; Bielenberg DR; Rodig SJ; Doiron R; Clifton MC; Kung AL; Strong RK; Zurakowski D; Moses MA
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3913-8. PubMed ID: 19237579
[TBL] [Abstract][Full Text] [Related]
3. Relationships of lipocalin 2 with breast tumorigenesis and metastasis.
Leng X; Wu Y; Arlinghaus RB
J Cell Physiol; 2011 Feb; 226(2):309-14. PubMed ID: 20857428
[TBL] [Abstract][Full Text] [Related]
4. HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Koh SA; Lee KH
Oncol Rep; 2015 Oct; 34(4):2179-87. PubMed ID: 26259977
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
[TBL] [Abstract][Full Text] [Related]
6. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.
Chakraborty S; Kaur S; Guha S; Batra SK
Biochim Biophys Acta; 2012 Aug; 1826(1):129-69. PubMed ID: 22513004
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
8. LCN2: Versatile players in breast cancer.
Bao Y; Yan Z; Shi N; Tian X; Li J; Li T; Cheng X; Lv J
Biomed Pharmacother; 2024 Feb; 171():116091. PubMed ID: 38171248
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion.
Gaudineau B; Fougère M; Guaddachi F; Lemoine F; de la Grange P; Jauliac S
J Cell Sci; 2012 Oct; 125(Pt 19):4475-86. PubMed ID: 22767506
[TBL] [Abstract][Full Text] [Related]
10. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
J Mol Med (Berl); 2009 Aug; 87(8):803-13. PubMed ID: 19466389
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.
Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.
Kobara H; Miyamoto T; Suzuki A; Asaka R; Yamada Y; Ishikawa K; Kikuchi N; Ohira S; Shiozawa T
Placenta; 2013 Nov; 34(11):1036-43. PubMed ID: 23972287
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.
Leng X; Ding T; Lin H; Wang Y; Hu L; Hu J; Feig B; Zhang W; Pusztai L; Symmans WF; Wu Y; Arlinghaus RB
Cancer Res; 2009 Nov; 69(22):8579-84. PubMed ID: 19887608
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis.
Ding L; Hanawa H; Ota Y; Hasegawa G; Hao K; Asami F; Watanabe R; Yoshida T; Toba K; Yoshida K; Ogura M; Kodama M; Aizawa Y
Circ J; 2010 Mar; 74(3):523-30. PubMed ID: 20057160
[TBL] [Abstract][Full Text] [Related]
15. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.
Abella V; Scotece M; Conde J; Gómez R; Lois A; Pino J; Gómez-Reino JJ; Lago F; Mobasheri A; Gualillo O
Biomarkers; 2015; 20(8):565-71. PubMed ID: 26671823
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 induces apoptosis in human hepatocellular carcinoma cells through activation of mitochondria pathways.
Chien MH; Ying TH; Yang SF; Yu JK; Hsu CW; Hsieh SC; Hsieh YH
Cell Biochem Biophys; 2012 Dec; 64(3):177-86. PubMed ID: 22707293
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
18. From the periphery to the brain: Lipocalin-2, a friend or foe?
Ferreira AC; Dá Mesquita S; Sousa JC; Correia-Neves M; Sousa N; Palha JA; Marques F
Prog Neurobiol; 2015 Aug; 131():120-36. PubMed ID: 26159707
[TBL] [Abstract][Full Text] [Related]
19. Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Montalto G; Cervello M; Polesel J; Libra M; McCubrey JA
Biochim Biophys Acta; 2016 Mar; 1863(3):438-448. PubMed ID: 26278055
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G
BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
